NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia
Open Access
- 10 June 2025
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (7) , 1794-1824
Abstract
Oral leukoplakia (OLK) is a common potentially malignant oral disorder with high risk of malignant transformation. While photodynamic therapy (PDT) offers a minimally invasive treatment for OLK, some patients show resistance to PDT and the mechanisms remain unclear. This study aims to identify key regulatory pathways driving PDT resistance in OLK. Single-cell RNA sequencing of OLK samples (three PDT-sensitive, three PDT-resistant) revealed significant NRF2 upregulation in resistant tissues. Validation across two independent cohorts ( n = 117) confirmed that p-NRF2 levels were significantly elevated in PDT-resistant cases, exhibiting strong predictive power for treatment response (AUC > 0.8). Mechanistically, NRF2 promotes CTNNB1 transcription, activates WNT signaling, modulates reactive oxygen species responses, and regulates keratinization, collectively contributing to PDT resistance. In a 4NQO-induced OLK mouse model, NRF2 inhibition combined with PDT effectively reversed OLK lesions and restored mucosal histology. These findings establish p-NRF2 as a valuable biomarker for guiding PDT regimens in OLK patients, reveal NRF2’s role in mediating PDT resistance via the WNT signaling pathway, and highlight NRF2 inhibition as a promising strategy to enhance PDT efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (82273320;82330029;82472686)
- National Natural Science Foundation of China (U19A2005;82270986;82470983)
- CAMS Innovation Fund for Medical Sciences (2019-I2M-5-004)
- 1.3.5 Project of Excellent Development of Discipline of West China Hospital of Sichuan University ((No. ZYYC21001)
This publication has 57 references indexed in Scilit:
- Enhancing 5-ALA-PDT efficacy against resistant tumor cells: Strategies and advancesLife Sciences, 2024
- Nivolumab for Patients With High-Risk Oral LeukoplakiaJAMA Oncology, 2024
- Oral Lichen Planus: An Update on Diagnosis and ManagementAmerican Journal of Clinical Dermatology, 2023
- CLINICAL EFFICACY OF PHOTODYNAMIC THERAPY IN MANAGEMENT OF ORAL POTENTIALLY MALIGNANT DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSISJournal of Evidence-Based Dental Practice, 2023
- Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein dockingComputers in Biology and Medicine, 2023
- Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral LeukoplakiaLaboratory Investigation, 2023
- Digital Image Analysis of Ki67 Heterogeneity Improves the Diagnosis and Prognosis of Gastroenteropancreatic Neuroendocrine NeoplasmsLaboratory Investigation, 2023
- Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung CancerAdvanced Materials, 2022
- The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An UpdateMedicinal Research Reviews, 2016
- An iterative knowledge‐based scoring function for protein–protein recognitionProteins: Structure, Function, and Bioinformatics, 2008